Abacus Backs LongueVue’s Buy

Abacus Finance Group was the Administrative Agent and Sole Lead Arranger for $17.5 million in senior secured credit facilities to support the recent leveraged buyout of Zavation Medical Products by LongueVue Capital.

“I have nothing but praise – Abacus Finance lived up to its reputation by proving to be a very flexible and reliable partner,” said LongueVue Founding Partner Rick Rees. “Their turnaround was quick and the execution seamless.”

Abacus provides cash flow-based senior financing to private equity-sponsored, lower-middle market companies that have EBITDA between $3 million and $15 million. Debt facilities can be as large as $60 million with a typical hold size ranging from $10 million to $30 million.  New York-based Abacus was formed in June 2011 and is an affiliate of New York Private Bank & Trust (www.abacusfinance.com).

Zavation designs, engineers, and manufactures a portfolio of spinal hardware used in thoracolumbar (the thoracic and lumbar regions of the spine), cervical, interbody fusion, and minimally invasive surgery. Other products include related medical instruments and micro-and-macro porous bone graft substitutes. Zavation’s products are sold through a network of more than 100 distributors in 35 states. The company has commercialized over 10 product families since its founding and has 10 additional products expected to launch over the next two years. Zavation, founded in 2010, has approximately 50 employees and operates a 24,000 square foot facility near Jackson in Flowood, MS (www.zavation.com).

“This was yet another new relationship for us, and we were impressed by the LongueVue team and the quality of the company they brought to us,” said Tim Clifford, President and CEO of Abacus.

LongueVue makes equity and debt investments in lower middle-market companies that have over $3 million of EBITDA and up to $150 million of annual revenue. Sectors of interest include business services, transportation and logistics, healthcare, energy services, and niche manufacturing. In March 2017, the firm held a final close of LongueVue Capital Partners III, LP. The new fund was oversubscribed and closed at its hard cap of $252 million. LongueVue was founded in 2001 and is based in New Orleans with additional offices in New York and Salt Lake City (www.lvcpartners.com).

“The Abacus team knows the medical device sector well,” said LongueVue Principal Ryan Nagim, “and was able to give us certainty of closure early in the process.”

“Rick’s and Ryan’s colleagues found early on that we are easy to work with and that our due diligence process flows smoothly – key aspects of what we call our Total Partnership Approach™. We look forward to working with them in the future,” said Eric Petersen, Senior Vice President at Abacus Finance.

Senior Associate Rafal Rydzewski also worked on this transaction for Abacus.

© 2017 Private Equity Professional | July 31, 2017

Print Friendly, PDF & Email

Related Articles

Abacus Backs River’s Buy of GAHH Abacus Finance Group was the Administrative Agent and Lead Arranger for $22 million in senior secured credit facilities to support the recent acquisit...
New Partner at Trive Capital Trive Capital has promoted Blake Bonner to Partner. Mr. Bonner’s responsibilities include identifying and evaluating investment opportunities, perform...
Genstar Promotes Two Genstar Capital has promoted Geoff Miller to Director and Rob Clark to Principal. “We are pleased to announce the promotions of Geoff and Rob,” sai...
New Managing Director at Grey Mountain Grey Mountain Partners has promoted Beth Lesniak to Managing Director. Ms. Lesniak joined Grey Mountain in 2009 and she is active in all areas of t...
The Seller’s Market Continues High valuations and abundant use of debt continued to mark completed deal activity in the first quarter of 2018, according to GF Data’s just-released ...
Drew Meyers Rejoins Seaport Seaport Capital has added Drew Meyers to its investment team as a new partner. Mr. Meyers previously worked at Seaport from 2001 to 2007. We are ex...